Wood, C. L.
Cheetham, T. D
Hollingsworth, K. G
Guglieri, M.
Ailins-Sahun, Y.
Punniyakodi, S.
Mayhew, A.
Straub, V.
Funding for this research was provided by:
Medical Research Council (MR/N020588/1)
Duchenne Now
Article History
Received: 12 October 2018
Accepted: 10 April 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: A favourable ethical opinion was obtained from the York NHS Research Ethics Committee (REC) prior to the start of the trial (15/NE/0332). Patients and their families were informed of this study verbally and with a patient information sheet and then given the opportunity to have any questions about the study answered by the trial investigators. Written informed consent was obtained from the parent(s)/guardian(s) of the boys and an assent process appropriate to the age of each boy was carried out, with the permission of the parent(s)/guardian(s) and where the child was intellectually capable.For children too young to consent but willing to assent the appropriate assent form was used. The original signed consent and assent forms will be retained in the Investigator Site File, with a copy in the clinical notes and a copy provided to the participant. The participants also specifically consented to their GP being informed of their participation in the study and additionally were given the option of consenting to an additional blood sample being taken for the Biobank.
: All participants provided written consent for their anonymised data to be published and disseminated appropriately. Written informed consent for publication of patient data was provided by the parents or legal guardians of underage participants on their behalf.
: The authors declare that they have no disclosures or competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.